Skip to main content
MODD
NASDAQ Life Sciences

FDA Clears Modular Medical's Pivot Software Upgrades Ahead of Q4 Launch

Tom Rudovsky · Reported by Benzinga
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.62
Mkt Cap
$28.202M
52W Low
$1.72
52W High
$30
52W Position info
110% above low
Off High info
88% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MODD has more than doubled off its 52-week low of $1.72.

Summary

Modular Medical received FDA clearance for software enhancements to its Pivot insulin delivery system, including customizable bolus dosing and UI improvements. The clearance arrives ahead of the planned Q4 commercial launch and follows the company's July FDA submission. This is a key regulatory milestone that de-risks the upcoming launch and supports the commercialization strategy across five U.S. markets. Shares rose 6.94% premarket to $3.70 on the news. The company remains in a liquidity-constrained position, with ongoing ATM sales and a recent $6.5M quarterly loss, so successful commercialization is critical.

At the time of this announcement, MODD was trading at $3.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.2M. The 52-week trading range was $1.72 to $30.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

MODD - Latest Insights

MODD
Nov 19, 2026, 9:00 AM EST
Source: ACCESS Newswire
Importance Score:
7
MODD
Nov 16, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
MODD
Oct 01, 2026, 9:24 AM EDT
Filing Type: DEF 14A
Importance Score:
8
MODD
Sep 04, 2026, 11:13 AM EDT
Source: Benzinga
Importance Score:
7
MODD
Aug 14, 2026, 5:25 PM EDT
Filing Type: 10-Q
Importance Score:
8